FDA Inspection 1085155 — SpecGx, LLC
The FDA completed an inspection of SpecGx, LLC on Mar 6, 2019 in Webster Groves, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Webster Groves, MO (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)